MacroGenics Return on Sales from 2010 to 2024

MGNX Stock  USD 14.96  0.74  5.20%   
Check MacroGenics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MacroGenics main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.1 M, Selling General Administrative of 37 M or Total Revenue of 89.7 M, as well as many exotic indicators such as Price To Sales Ratio of 10.6 K, Dividend Yield of 0.0 or Operating Cycle of 824. MacroGenics financial statements analysis is a perfect complement when working with MacroGenics Valuation or Volatility modules.
  
This module can also supplement MacroGenics' financial leverage analysis and stock options assessment as well as various MacroGenics Technical models . Check out the analysis of MacroGenics Correlation against competitors.
For more information on how to buy MacroGenics Stock please use our How to Invest in MacroGenics guide.

About MacroGenics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include MacroGenics income statement, its balance sheet, and the statement of cash flows. MacroGenics investors use historical funamental indicators, such as MacroGenics's Return on Sales, to determine how well the company is positioned to perform in the future. Although MacroGenics investors may use each financial statement separately, they are all related. The changes in MacroGenics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on MacroGenics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on MacroGenics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in MacroGenics. Please read more on our technical analysis and fundamental analysis pages.
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. The company was incorporated in 2000 and is headquartered in Rockville, Maryland. Macrogenics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 427 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards MacroGenics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, MacroGenics' short interest history, or implied volatility extrapolated from MacroGenics options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether MacroGenics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of MacroGenics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Macrogenics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Macrogenics Stock:
Check out the analysis of MacroGenics Correlation against competitors.
For more information on how to buy MacroGenics Stock please use our How to Invest in MacroGenics guide.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Complementary Tools for MacroGenics Stock analysis

When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Is MacroGenics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MacroGenics. If investors know MacroGenics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MacroGenics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.15)
Revenue Per Share
0.949
Quarterly Revenue Growth
(0.85)
Return On Assets
(0.36)
Return On Equity
(0.06)
The market value of MacroGenics is measured differently than its book value, which is the value of MacroGenics that is recorded on the company's balance sheet. Investors also form their own opinion of MacroGenics' value that differs from its market value or its book value, called intrinsic value, which is MacroGenics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MacroGenics' market value can be influenced by many factors that don't directly affect MacroGenics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MacroGenics' value and its price as these two are different measures arrived at by different means. Investors typically determine if MacroGenics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MacroGenics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.